Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab …
…, IT Hansen, G Kollerup, L Linde… - … : Official Journal of …, 2010 - Wiley Online Library
Objective To compare tumor necrosis factor α inhibitors directly regarding the rates of treatment
response, remission, and the drug survival rate in patients with rheumatoid arthritis (RA), …
response, remission, and the drug survival rate in patients with rheumatoid arthritis (RA), …
Health-related quality of life: validity, reliability, and responsiveness of SF-36, EQ-15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis
L Linde, J Sørensen, M Østergaard… - The Journal of …, 2008 - jrheum.org
Objective To compare validity, reliability, and responsiveness of generic and disease specific
health-related quality of life (HRQOL) instruments in rheumatoid arthritis (RA). Methods …
health-related quality of life (HRQOL) instruments in rheumatoid arthritis (RA). Methods …
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides–a follow-up study from the DANBIO …
…, TH Hansen, DV Jensen, L Linde… - Annals of the …, 2013 - ard.bmj.com
Objectives To investigate the incidence of cancer in arthritis patients treated with or without
TNFα inhibitors (TNF-I). Methods Arthritis patients from the DANBIO database were followed-…
TNFα inhibitors (TNF-I). Methods Arthritis patients from the DANBIO database were followed-…
Interleukin-6-receptor polymorphisms rs12083537, rs2228145, and rs4329505 as predictors of response to tocilizumab in rheumatoid arthritis
C Enevold, B Baslund, L Linde… - Pharmacogenetics …, 2014 - journals.lww.com
Tocilizumab (TCZ), a monoclonal antibody targeting the human interleukin-6-receptor (IL-6R),
is indicated for the treatment of rheumatoid arthritis (RA). We examined whether three …
is indicated for the treatment of rheumatoid arthritis (RA). We examined whether three …
[HTML][HTML] Mechanical circulatory support for refractory out-of-hospital cardiac arrest: a Danish nationwide multicenter study
SR Mørk, C Stengaard, L Linde, JE Møller, LO Jensen… - Critical Care, 2021 - Springer
Background Mechanical circulatory support (MCS) with either extracorporeal membrane
oxygenation or Impella has shown potential as a salvage therapy for patients with refractory out-…
oxygenation or Impella has shown potential as a salvage therapy for patients with refractory out-…
[HTML][HTML] Left-Ventricular Unloading With Impella During Refractory Cardiac Arrest Treated With Extracorporeal Cardiopulmonary Resuscitation: A Systematic Review …
…, B Schrage, D Westermann, L Linde… - Critical Care …, 2024 - journals.lww.com
OBJECTIVES: Extracorporeal cardiopulmonary resuscitation (ECPR) is the implementation
of venoarterial extracorporeal membrane oxygenation (VA-ECMO) during refractory cardiac …
of venoarterial extracorporeal membrane oxygenation (VA-ECMO) during refractory cardiac …
Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?
L Linde, J Sørensen, M Østergaard… - The Journal of …, 2010 - jrheum.org
Objective. To compare health-related quality of life (HRQOL) of patients with rheumatoid
arthritis (RA) to that of the general population and to investigate the association with disease …
arthritis (RA) to that of the general population and to investigate the association with disease …
What factors influence the health status of patients with rheumatoid arthritis measured by the SF-12v2 Health Survey and the Health Assessment Questionnaire?
L Linde, J Sørensen, M Østergaard… - The Journal of …, 2009 - jrheum.org
Objective. The Health Assessment Questionnaire Disability Index (HAQ) is a widely used
outcome measure in rheumatoid arthritis (RA), whereas the SF-12v2 Health Survey (SF-12) …
outcome measure in rheumatoid arthritis (RA), whereas the SF-12v2 Health Survey (SF-12) …
[HTML][HTML] Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration
LM Ørnbjerg, L Linde, S Georgiadis… - Seminars in arthritis and …, 2022 - Elsevier
Objectives In patients with axial spondyloarthritis (axSpA) initiating their first tumor necrosis
factor alpha-inhibitor (TNFi), we aimed to identify common baseline predictors of Ankylosing …
factor alpha-inhibitor (TNFi), we aimed to identify common baseline predictors of Ankylosing …
Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases
…, S Jacobsen, M Khamashta, R Levy, L Linde… - The Lancet …, 2023 - thelancet.com
6 US Food & Drug Administration. Biosimilar product information. May 25, 2023. https://www.
fda. gov/drugs/biosimilars/biosimilar-productinformation (accessed July 24, 2023). 7 Emery …
fda. gov/drugs/biosimilars/biosimilar-productinformation (accessed July 24, 2023). 7 Emery …